207 related articles for article (PubMed ID: 26267123)
41. [Value of susceptibility weighted imaging in hepatic fibrosis staging by using MR in a rabbit model].
Jiang J; Deng L; Ruan J; Cheng X; Zou L
Zhonghua Yi Xue Za Zhi; 2016 May; 96(17):1371-6. PubMed ID: 27180758
[TBL] [Abstract][Full Text] [Related]
42. Fast macromolecular proton fraction mapping of the human liver in vivo for quantitative assessment of hepatic fibrosis.
Yarnykh VL; Tartaglione EV; Ioannou GN
NMR Biomed; 2015 Dec; 28(12):1716-25. PubMed ID: 26503401
[TBL] [Abstract][Full Text] [Related]
43. Diffusion-weighted MRI versus transient elastography in quantification of liver fibrosis in patients with chronic cholestatic liver diseases.
Kovač JD; Daković M; Stanisavljević D; Alempijević T; Ješić R; Seferović P; Maksimović R
Eur J Radiol; 2012 Oct; 81(10):2500-6. PubMed ID: 22100369
[TBL] [Abstract][Full Text] [Related]
44. MRI-based staging of hepatic fibrosis: Comparison of intravoxel incoherent motion diffusion-weighted imaging with magnetic resonance elastography.
Ichikawa S; Motosugi U; Morisaka H; Sano K; Ichikawa T; Enomoto N; Matsuda M; Fujii H; Onishi H
J Magn Reson Imaging; 2015 Jul; 42(1):204-10. PubMed ID: 25223820
[TBL] [Abstract][Full Text] [Related]
45. An experimental study on the assessment of rabbit hepatic fibrosis by using magnetic resonance T1ρ imaging.
Jiang J; Huang B; Bin G; Chen S; Feng F; Zou L
Magn Reson Imaging; 2016 Apr; 34(3):308-11. PubMed ID: 26597838
[TBL] [Abstract][Full Text] [Related]
46. Intravoxel incoherent motion MRI for liver fibrosis assessment: a pilot study.
Chung SR; Lee SS; Kim N; Yu ES; Kim E; Kühn B; Kim IS
Acta Radiol; 2015 Dec; 56(12):1428-36. PubMed ID: 25414372
[TBL] [Abstract][Full Text] [Related]
47. Diffusion Tensor Imaging for Evaluating Biliary Atresia in Infants and Neonates.
Liu B; Cai J; Zhu J; Zheng H; Zhang Y; Wang L
PLoS One; 2016; 11(12):e0168477. PubMed ID: 27992499
[TBL] [Abstract][Full Text] [Related]
48. Contrast-enhanced ultrasound for quantitative assessment of portal pressure in canine liver fibrosis.
Zhai L; Qiu LY; Zu Y; Yan Y; Ren XZ; Zhao JF; Liu YJ; Liu JB; Qian LX
World J Gastroenterol; 2015 Apr; 21(15):4509-16. PubMed ID: 25914459
[TBL] [Abstract][Full Text] [Related]
49. Comparison of magnetic resonance elastography and diffusion-weighted imaging for staging hepatic fibrosis.
Zou LQ; Chen J; Pan L; Jiang JZ; Xing W
Chin Med J (Engl); 2015 Mar; 128(5):620-5. PubMed ID: 25698193
[TBL] [Abstract][Full Text] [Related]
50. [Comparative study on clinical and pathological changes of liver fibrosis with diffusion-weighted imaging].
Zhou ML; Yan FH; Xu PJ; Chen CZ; Shen JZ; Li RC; Ji Y; Shi JY
Zhonghua Yi Xue Za Zhi; 2009 Jul; 89(25):1757-61. PubMed ID: 19862980
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of the mean and entropy of apparent diffusion coefficient values in chronic hepatitis C: correlation with pathologic fibrosis stage and inflammatory activity grade.
Fujimoto K; Tonan T; Azuma S; Kage M; Nakashima O; Johkoh T; Hayabuchi N; Okuda K; Kawaguchi T; Sata M; Qayyum A
Radiology; 2011 Mar; 258(3):739-48. PubMed ID: 21248235
[TBL] [Abstract][Full Text] [Related]
52. Intravoxel incoherent motion MRI evaluation for the staging of liver fibrosis in a rat model.
Hu G; Chan Q; Quan X; Zhang X; Li Y; Zhong X; Lin X
J Magn Reson Imaging; 2015 Aug; 42(2):331-9. PubMed ID: 25384923
[TBL] [Abstract][Full Text] [Related]
53. Diffusion-weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C.
Lewin M; Poujol-Robert A; Boëlle PY; Wendum D; Lasnier E; Viallon M; Guéchot J; Hoeffel C; Arrivé L; Tubiana JM; Poupon R
Hepatology; 2007 Sep; 46(3):658-65. PubMed ID: 17663420
[TBL] [Abstract][Full Text] [Related]
54. Quantitative analysis of susceptibility-weighted magnetic resonance imaging in chronic hepatitis in rats.
Cai Y; Huang MP; Wang XF; Lu X; Luo L; Shu J
Magn Reson Imaging; 2018 Dec; 54():71-76. PubMed ID: 30130549
[TBL] [Abstract][Full Text] [Related]
55. Diffusion-weighted imaging of hyperpolarized [
Marco-Rius I; Gordon JW; Mattis AN; Bok R; Delos Santos R; Sukumar S; Larson PEZ; Vigneron DB; Ohliger MA
J Magn Reson Imaging; 2018 Jan; 47(1):141-151. PubMed ID: 28419644
[TBL] [Abstract][Full Text] [Related]
56. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience.
Taouli B; Tolia AJ; Losada M; Babb JS; Chan ES; Bannan MA; Tobias H
AJR Am J Roentgenol; 2007 Oct; 189(4):799-806. PubMed ID: 17885048
[TBL] [Abstract][Full Text] [Related]
57. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
[TBL] [Abstract][Full Text] [Related]
58. Magnetic resonance quantification of non-Gaussian water diffusion in hepatic fibrosis staging: a pilot study of diffusion kurtosis imaging to identify reversible hepatic fibrosis.
Liu T; Hu J; Liu Y; Chen H; Guo D
Ann Transl Med; 2021 Oct; 9(20):1569. PubMed ID: 34790775
[TBL] [Abstract][Full Text] [Related]
59. The use of DWI to assess spleen and liver quantitative ADC changes in the detection of liver fibrosis stages in chronic viral hepatitis.
Cece H; Ercan A; Yıldız S; Karakas E; Karakas O; Boyacı FN; Aydogan T; Karakas EY; Cullu N; Ulas T
Eur J Radiol; 2013 Aug; 82(8):e307-12. PubMed ID: 23518145
[TBL] [Abstract][Full Text] [Related]
60. Diffusion-weighted MRI in evaluating liver fibrosis: a feasibility study in cirrhotic patients.
Girometti R; Furlan A; Bazzocchi M; Soldano F; Isola M; Toniutto P; Bitetto D; Zuiani C
Radiol Med; 2007 Apr; 112(3):394-408. PubMed ID: 17440695
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
